Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, n3m3sis
Search This Board: 
Last Post: 10/19/2017 7:22:59 PM - Followers: 143 - Board type: Free - Posts Today: 44


Pluristem Therapeutics Inc. (Nasdaq: PSTI)




Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172


CIK:  0001158780


Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 



Clinical Program:

Recent News and Press:






Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501


Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Current Report Filing (8-k) 02:41 PM
PSTI News: FDA Grants Pluristem Orphan Drug Designation for Its PLX-R18 Cell Therapy as Treatment for Acute Radiation Syndrome 07:30 AM
PSTI News: New Published Data Highlights the Potential of Pluristem's PLX Cells in Improving Cardiac Function in Diabetes 10/16/2017 07:00:00 AM
PSTI News: $7.9 Million Granted to nTRACK Collaborative Project Designed to Study Pluristem’s PLX-PAD Cells 10/02/2017 07:00:00 AM
PSTI News: Pluristem Receives Positive Feedback from FDA and EMA as Company Prepares for Phase III Trial of PLX-PAD to Support Recovery ... 09/26/2017 07:00:00 AM
News News Alert: Current Report Filing (8-k) 10/19/2017 02:41:41 PM
#7381   yaki twins may be over their headsThis is zzaatt 10/19/17 07:22:59 PM
#7380   Nice Call Today, Spot on Again with Facts.... bluehorsesho 10/19/17 06:56:23 PM
#7379   Pluristem Demonstrates the Potential of Its PLX Cells FDApproved 10/19/17 05:14:53 PM
#7378   Pluristem Demonstrates the Potential of Its PLX Cells FDApproved 10/19/17 05:07:24 PM
#7377   Pluristem Demonstrates the Potential of Its PLX Cells FDApproved 10/19/17 05:05:23 PM
#7376   Wow a gain of 3.45% today. Not far Scott999 10/19/17 04:36:13 PM
#7375   fast track des is alright, orphan status is thesaud 10/19/17 04:28:09 PM
#7374   Cell Culture Advances in the Age of Immunotherapy FDApproved 10/19/17 04:22:59 PM
#7373   Cell Culture Advances in the Age of Immunotherapy. FDApproved 10/19/17 04:21:33 PM
#7372   Maybe the fact that absolutely jack squat cane SrdghJack 10/19/17 03:24:07 PM
#7371   Do small startup companies gift themselves almost 4% Scott999 10/19/17 03:15:10 PM
#7370   Just because it's negative, doesn't mean it's not zzaatt 10/19/17 01:06:05 PM
#7369   Pluristem's PLX-R18 cell therapy an Orphan Drug in midastouch017 10/19/17 01:04:58 PM
#7368   It Looks Like Pluristem Wants The ATM midastouch017 10/19/17 12:44:44 PM
#7367   Among the benefits of Orphan Drug status midastouch017 10/19/17 12:37:05 PM
#7366   Any Revenue Generated from this Orphan Status? Melon4head 10/19/17 12:35:08 PM
#7365   In apropos orphan drug status and price midastouch017 10/19/17 12:33:29 PM
#7364   This Is Pluristem's 4th Orphan Drug Designation ! FDApproved 10/19/17 12:02:56 PM
#7363   1,334,000 Shares Traded On The Non-ATM TASE ! PPS-Close-$1.75 FDApproved 10/19/17 10:55:00 AM
#7362   Is it common sense to be wrong on Scott999 10/19/17 10:12:13 AM
#7361   Exactly my point. Just a guess as to Scott999 10/19/17 10:09:28 AM
#7359   As you don't like what we have to Scott999 10/19/17 10:04:33 AM
#7358   May not be able to prove the ATM TC43 10/19/17 10:04:29 AM
#7357   Funny I was searching importance of orphan drug Scott999 10/19/17 09:58:09 AM
#7356   Glad to see your return Blue. Well said. zzaatt 10/19/17 09:56:04 AM
#7355   Observation Of The PPS ! FDApproved 10/19/17 09:52:53 AM
#7354   And what are you basing that statement on? Scott999 10/19/17 09:49:06 AM
#7353   It Looks Like Pluristem Wants The ATM Selling FDApproved 10/19/17 09:43:48 AM
#7352   Another [b]"Important"[/b] New Event Added Today ! FDApproved 10/19/17 09:19:44 AM
#7351   “Pluristem has a vast and dynamic program developing FDApproved 10/19/17 09:15:19 AM
#7350   Lots of red PM between 1.86 - 1.89 midas716 10/19/17 08:55:24 AM
#7349   Looking for it to hold here, maybe a midas716 10/19/17 08:50:19 AM
#7348   Not as many have access to the pre-market n3m3sis 10/19/17 08:46:32 AM
#7347   Yep. Coming down a tad now. Doesn't seem midas716 10/19/17 08:43:48 AM
#7346   Confirmed! Nice action on the TASE after news.. n3m3sis 10/19/17 08:40:41 AM
#7345   Refresh your screen on TASE. TH is now midas716 10/19/17 08:33:17 AM
#7344   PSTI Still has the TH symbol next to it.... n3m3sis 10/19/17 08:23:57 AM
#7343   The TASE Is Still Halted ??? FDApproved 10/19/17 08:09:49 AM
#7342   No-one knows what is going on behind the n3m3sis 10/19/17 08:07:33 AM
#7341   Shorts Will Get Spanked Today ! FDApproved 10/19/17 08:06:24 AM
#7340   This is some very good news. One that Scott999 10/19/17 07:55:40 AM
#7339   showing 1.85 in pm! thesaud 10/19/17 07:41:33 AM
#7338   FDA Grants Pluristem Orphan Drug Designation for Its FDApproved 10/19/17 07:33:43 AM
#7337   Glad to see your return Blue. Well said. Scott999 10/18/17 08:49:57 PM
#7336   If we don't speak up about our concerns bluehorsesho 10/18/17 06:56:47 PM
#7335   We all know the risks and know the Scott999 10/18/17 06:24:45 PM
#7334   If you don't like the risk of an Rbrown1165 10/18/17 04:19:52 PM
#7333   Jack. Just To Clarify ! FDApproved 10/18/17 02:25:21 PM
#7332   No product approval, no partnership, no contracts zzaatt 10/18/17 01:56:52 PM
#7331   I’m starting to think that if really good SrdghJack 10/18/17 01:34:15 PM